HealthDecember 05, 2014

Wolters Kluwer integrates Lexicomp Online with Facts & Comparisons Off-Label, VisualDx drug eruption content

Enhancements are part of ongoing integration of Wolters Kluwer Clinical Drug Information solutions to deliver clinicians extensive medication decision support at the point of care.

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp® Online™, its hospital-wide referential drug information solution, now includes its industry-leading Facts & Comparisons® Off-Label database and VisualDx® drug eruption content. The enhancements are part of an ongoing integration of Wolters Kluwer Clinical Drug Information solutions to deliver to clinicians extensive medication decision support at the point of care.

The Facts & Comparisons Off-Label database provides information on more than 1,200 off-label medication uses, therapy statements, and evidence ratings, enhancing patient safety and providing valuable context. Users can also access nearly 350 in-depth off-label monographs including dosing studies and risk/benefits discussion for more informed decision-making. Availability of off-label indication information helps improve efficiencies by providing a summary statement of uses within core drug content while also enabling more in-depth research with intuitive access to a deeper level of information to support treatment recommendations and clinician education.

Also newly integrated with Lexicomp Online is industry-leading VisualDx drug eruption content to help clinicians identify drug-induced conditions of the skin. Offered by Logical Images, VisualDx is recognized as the premier solution that aids clinicians in the identification of a variety of skin lesions. By entering visual and other cues, such as lesion type, clinicians can quickly and easily confirm skin reactions and link directly to drug eruption content within Lexicomp drug monographs in the Warnings and Precautions fields. This integration also helps clinicians identify appropriate ICD-9 and ICD-10 codes and provides additional related information, such as supportive patient care and therapy options.

"Health systems and clinicians have long valued the strength of Lexicomp Online for delivering powerful and relevant drug information at the point of care, where it is most needed," said Steven Kerscher, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. "Incorporation of rich, evidence-based content from Facts & Comparisons, VisualDx and other trusted Wolters Kluwer applications enhances this value by supporting pharmacotherapy decisions that contribute to improved patient safety and clinical outcomes."

Solutions
Lexicomp
Evidence-based drug reference solution used in the workflow and on-the-go
Clinicians choose Lexicomp® for evidence-based drug information in the workflow and on-the-go. Studies show that Lexicomp is the preferred drug reference solution for care teams.
About Wolters kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the health, tax & accounting, governance, risk & compliance, and legal & regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.